TransMedics Group ensures safe and reliable transport of organs. Profit doubling, forecast increase, and high short-selling rate indicate a potential short squeeze.

Reading Time: 1 minute
TransMedics Group (TMDX;i) is a leading provider of innovative Organ Care Systems (OCS) aimed at significantly improving the preservation and viability of donor organs for transplantation. OCS is a portable platform that maintains organs outside the body in a near-physiological state, thereby enhancing the success rate of transplants. The transport of organs poses a significant challenge and often leads to complications. The strong expansion of OCS-NOP usage in the USA, particularly in liver and heart transplants (both DBD and DCD), as well as...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.